EP3436446
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.3.2017EP published:
7.6.2023EP application number:
17716763.2
EPO information:
European Patent Register
Max expiry date:
30.3.2037
Title in English:
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATORLanguage of the patent:
English
Timeline
Today
31.3.2017EP application
7.6.2023EP Publication
Owner
Name:
Vertex Pharmaceuticals IncorporatedAddress:
50 Northern Avenue, Boston, MA 02210, US
Inventor
Name:
BEAR, BrianAddress:
Boston MA 02210, US
Name:
CLEMENS, JeremyAddress:
Boston MA 02210, US
Name:
CLEVELAND, ThomasAddress:
Boston MA 02210, US
Name:
COON, Timothy, RichardAddress:
Boston MA 02210, US
Name:
GROOTENHUIS, Peter, Diederik JanAddress:
Boston MA 02210, US
Name:
FRIEMAN, Bryan, A.Address:
Boston MA 02210, US
Name:
HADIDA RUAH, Sara S.Address:
Boston MA 02210, US
Name:
KHATUYA, HaripadaAddress:
Boston MA 02210, US
Name:
KRENITSKY, Paul, J.Address:
Boston MA 02210, US
Name:
MILLER, Mark, ThomasAddress:
Boston MA 02210, US
Name:
SILINA, AlinaAddress:
Boston MA 02210, US
Name:
UY, JohnnyAddress:
Boston MA 02210, US
Name:
ZHOU, JinglanAddress:
Boston MA 02210, US
Priority
Number:
201662316043 PDate:
31.3.2016Country:
US
Classification
Categories:
C07D 401/14, C07D 213/82, A61P 11/00, A61K 31/44